{
"info": {
"nct_id": "NCT02749617",
"official_title": "A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma",
"inclusion_criteria": "* Patients with diagnosis of multiple myeloma according to criteria of the International Myeloma Working Group\n* Patients in whom a LEN-DEX-based treatment regimen is indicated\n* Adult patients ≥ 19 years of age who are able to freely provide informed consent\nHealthy volunteers allowed\nMust have minimum age of 19 Years",
"exclusion_criteria": "* Concomitant antiplatelet or anticoagulant use\n* Calculated creatinine clearance < 30 mL/min by Cockcroft-Gault formula\n* Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 3 times upper limit of normal (ULN)\n* Total bilirubin > 2 x ULN\n* Thrombocytopenia < 50 x 10 gigalitres (Gl)\n* High bleeding risk or spontaneously prolonged prothrombin time or activated partial thromboplastin time > 1.5 x ULN\n* Body weight <50 or >120 kg\n* Concomitant use of CYP3A4 or p-glycoprotein inducers or inhibitors\n* Use of Ginkgo biloba or St. John's Wort within 14 days before first dose of study drug\n* Dexamethasone use within last 3 months\n* Women of Childbearing potential without proper contraceptive measures, pregnancy or breast feeding\n* Life expectancy less than 3 months\n* Inability to swallow or issues with malabsorption\n* Any other medical, social, logistical, geographical or psychological factors, which in the opinion of the investigator, would prohibit follow-up, compliance and study completion",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients with diagnosis of multiple myeloma according to criteria of the International Myeloma Working Group",
"criterions": [
{
"exact_snippets": "diagnosis of multiple myeloma",
"criterion": "multiple myeloma diagnosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "according to criteria of the International Myeloma Working Group",
"criterion": "International Myeloma Working Group criteria",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients in whom a LEN-DEX-based treatment regimen is indicated",
"criterions": [
{
"exact_snippets": "LEN-DEX-based treatment regimen is indicated",
"criterion": "LEN-DEX-based treatment regimen",
"requirements": [
{
"requirement_type": "indication",
"expected_value": true
}
]
}
]
},
{
"line": "* Adult patients ≥ 19 years of age who are able to freely provide informed consent",
"criterions": [
{
"exact_snippets": "Adult patients ≥ 19 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 19,
"unit": "years"
}
}
]
},
{
"exact_snippets": "able to freely provide informed consent",
"criterion": "ability to provide informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 19 Years",
"criterions": [
{
"exact_snippets": "minimum age of 19 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 19,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Concomitant antiplatelet or anticoagulant use",
"criterions": [
{
"exact_snippets": "Concomitant antiplatelet or anticoagulant use",
"criterion": "antiplatelet use",
"requirements": [
{
"requirement_type": "concomitant use",
"expected_value": true
}
]
},
{
"exact_snippets": "Concomitant antiplatelet or anticoagulant use",
"criterion": "anticoagulant use",
"requirements": [
{
"requirement_type": "concomitant use",
"expected_value": true
}
]
}
]
},
{
"line": "* Calculated creatinine clearance < 30 mL/min by Cockcroft-Gault formula",
"criterions": [
{
"exact_snippets": "Calculated creatinine clearance < 30 mL/min by Cockcroft-Gault formula",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "calculation method",
"expected_value": "Cockcroft-Gault formula"
},
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 30,
"unit": "mL/min"
}
}
]
}
]
},
{
"line": "* Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 3 times upper limit of normal (ULN)",
"criterions": [
{
"exact_snippets": "Alanine aminotransferase (ALT) ... > 3 times upper limit of normal (ULN)",
"criterion": "Alanine aminotransferase (ALT)",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "times ULN"
}
}
]
},
{
"exact_snippets": "aspartate aminotransferase (AST) ... > 3 times upper limit of normal (ULN)",
"criterion": "aspartate aminotransferase (AST)",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "times ULN"
}
}
]
}
]
},
{
"line": "* Total bilirubin > 2 x ULN",
"criterions": [
{
"exact_snippets": "Total bilirubin > 2 x ULN",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Thrombocytopenia < 50 x 10 gigalitres (Gl)",
"criterions": [
{
"exact_snippets": "Thrombocytopenia < 50 x 10 gigalitres (Gl)",
"criterion": "thrombocytopenia",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": "<",
"value": 50,
"unit": "x 10 gigalitres (Gl)"
}
}
]
}
]
},
{
"line": "* High bleeding risk or spontaneously prolonged prothrombin time or activated partial thromboplastin time > 1.5 x ULN",
"criterions": [
{
"exact_snippets": "High bleeding risk",
"criterion": "bleeding risk",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "high"
}
]
},
{
"exact_snippets": "spontaneously prolonged prothrombin time",
"criterion": "prothrombin time",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "prolonged"
}
]
},
{
"exact_snippets": "activated partial thromboplastin time > 1.5 x ULN",
"criterion": "activated partial thromboplastin time",
"requirements": [
{
"requirement_type": "comparison",
"expected_value": {
"operator": ">",
"value": 1.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Body weight <50 or >120 kg",
"criterions": [
{
"exact_snippets": "Body weight <50 or >120 kg",
"criterion": "body weight",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 50,
"unit": "kg"
},
{
"operator": ">",
"value": 120,
"unit": "kg"
}
]
}
}
]
}
]
},
{
"line": "* Concomitant use of CYP3A4 or p-glycoprotein inducers or inhibitors",
"criterions": [
{
"exact_snippets": "Concomitant use of CYP3A4 or p-glycoprotein inducers or inhibitors",
"criterion": "concomitant use of CYP3A4 inducers or inhibitors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Concomitant use of CYP3A4 or p-glycoprotein inducers or inhibitors",
"criterion": "concomitant use of p-glycoprotein inducers or inhibitors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Use of Ginkgo biloba or St. John's Wort within 14 days before first dose of study drug",
"criterions": [
{
"exact_snippets": "Use of Ginkgo biloba ... within 14 days before first dose of study drug",
"criterion": "Ginkgo biloba use",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 14,
"unit": "days"
}
}
]
},
{
"exact_snippets": "Use of ... St. John's Wort within 14 days before first dose of study drug",
"criterion": "St. John's Wort use",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 14,
"unit": "days"
}
}
]
}
]
},
{
"line": "* Dexamethasone use within last 3 months",
"criterions": [
{
"exact_snippets": "Dexamethasone use within last 3 months",
"criterion": "Dexamethasone use",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within last 3 months"
}
]
}
]
},
{
"line": "* Women of Childbearing potential without proper contraceptive measures, pregnancy or breast feeding",
"criterions": [
{
"exact_snippets": "Women of Childbearing potential",
"criterion": "women of childbearing potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "without proper contraceptive measures",
"criterion": "contraceptive measures",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breast feeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Life expectancy less than 3 months",
"criterions": [
{
"exact_snippets": "Life expectancy less than 3 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Inability to swallow or issues with malabsorption",
"criterions": [
{
"exact_snippets": "Inability to swallow",
"criterion": "swallowing ability",
"requirements": [
{
"requirement_type": "ability",
"expected_value": false
}
]
},
{
"exact_snippets": "issues with malabsorption",
"criterion": "malabsorption",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Any other medical, social, logistical, geographical or psychological factors, which in the opinion of the investigator, would prohibit follow-up, compliance and study completion",
"criterions": [
{
"exact_snippets": "Any other medical ... factors",
"criterion": "medical factors",
"requirements": [
{
"requirement_type": "opinion of the investigator",
"expected_value": "prohibit follow-up, compliance and study completion"
}
]
},
{
"exact_snippets": "Any other ... social ... factors",
"criterion": "social factors",
"requirements": [
{
"requirement_type": "opinion of the investigator",
"expected_value": "prohibit follow-up, compliance and study completion"
}
]
},
{
"exact_snippets": "Any other ... logistical ... factors",
"criterion": "logistical factors",
"requirements": [
{
"requirement_type": "opinion of the investigator",
"expected_value": "prohibit follow-up, compliance and study completion"
}
]
},
{
"exact_snippets": "Any other ... geographical ... factors",
"criterion": "geographical factors",
"requirements": [
{
"requirement_type": "opinion of the investigator",
"expected_value": "prohibit follow-up, compliance and study completion"
}
]
},
{
"exact_snippets": "Any other ... psychological factors",
"criterion": "psychological factors",
"requirements": [
{
"requirement_type": "opinion of the investigator",
"expected_value": "prohibit follow-up, compliance and study completion"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}